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Abstract
Scabies is known to be a public health problem in many settings but the majority of recent
data is from rural settings in the Pacific. There is a need for high quality data from sub-Saha-
ran Africa and peri-urban settings to inform scale up of scabies control efforts. There have
been anecdotal reports of scabies being a public health problem in Liberia but robust data
are lacking. We conducted a cross-sectional cluster-randomised prevalence survey for sca-
bies in a peri-urban community in Monrovia, Liberia in February-March 2020. Participants
underwent a standardised examination conducted by trained local health care workers.
Health related quality of life (HRQoL) was assessed using age-appropriate versions of the
dermatology life quality index (DLQI). Prevalence estimates were calculated accounting for
clustering at community and household levels and associations with key demographic vari-
ables assessed through multivariable random-effects logistic regression. 1,318 participants
from 477 households were surveyed. The prevalence of scabies was 9.3% (95% CI: 6.5–
13.2%), across 75 (19.7%) households; impetigo or infected scabies prevalence was 0.8%
(95% CI: 0.4–1.9%). The majority (52%) of scabies cases were classified as severe. Sca-
bies prevalence was lower in females and higher in the youngest age group; no associations
were found with other collected demographic or socio-economic variables. DLQI scores
indicated a very or extremely large effect on HRQoL in 29% of adults and 18% of children
diagnosed with scabies. Our study indicates a substantial burden of scabies in this peri-
urban population in Liberia. This was associated with significant impact on quality of life,
highlighting the need for action to control scabies in this population. Further work is needed
to assess the impact of interventions in this context on both the prevalence of scabies and
quality of life.
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Author summary
Scabies is an infestation with a microscopic mite which affects many people living in low-
resource tropical countries. It causes intense itching, which can lead to complications
through bacterial infection and poor quality of life. To help develop global scabies control
programmes, we need a better understanding of how common it is across different tropi-
cal settings. We conducted a survey to assess the burden of scabies and bacterial skin
infection in a random sample of people living in a community in Monrovia, Liberia.
Information about participants and their household were collected and their skin was
examined; those with skin conditions were asked about its impact on quality of life.
We examined 1,318 participants and found that almost 10% of people had scabies. Sca-
bies was more common in young children and more common in male children than
female children. We found that there was a large impact on quality of life due mostly to
the itching that scabies causes and to people feeling embarrassed or sad because of their
skin condition. This scabies survey is one of the first conducted across all age groups in
recent years in sub-Saharan Africa and indicates a substantial burden and impact on qual-
ity of life. More work is needed to understand how common scabies is in different settings
and the impact that different treatment strategies may have.
Background
Scabies is a parasitic infestation of the skin by the mite Sarcoptes scabiei var. hominis. The pres-
ence of mite products in the stratum corneum drives a host hypersensitivity reaction that
results in intense pruritis and rash, which can lead to disrupted sleep, poor concentration and
social stigma [1]. Scabies is estimated to affect over 200 million people globally [2] and the
highest prevalence is thought to occur in low-resource tropical settings [3]. Scabies can be
complicated by secondary bacterial infection with Streptococcus pyogenes and Staphylococcus
aureus [3, 4] and the risk of severe conditions including post streptococcal glomerulonephritis,
acute rheumatic fever and rheumatic heart disease [3, 5]. In view of this burden of disease, sca-
bies was added to the WHO Neglected Tropical Disease portfolio in 2017 [6], with a recom-
mendation that scabies management should be incorporated in the universal health coverage
package of care [7].
The development of an effective global control strategy for scabies requires a sound under-
standing of the disease burden, however robust epidemiological data for the condition is sparse
for a number of reasons [8]. Firstly, many settings do not have accurate estimates of scabies
prevalence. Routine health data, if collected, often under-estimates the true population burden,
arising from reasons including ‘normalisation’ of skin lesions by affected individuals and their
under-recognition by clinical staff [9]. A 2015 systematic review of scabies and impetigo preva-
lence indicated wide variation in prevalence estimates globally; a consistently high burden was
seen in many resource-limited settings, particularly in Pacific countries, with the highest prev-
alence documented in Papua New Guinea at 71% [10]. Prevalence figures from sub-Saharan
African countries were lower but few high-quality, population-based data were available. Sec-
ondly, until recently there has been a lack of standardised criteria for diagnosis of scabies [10].
The International Alliance for the Control of Scabies (IACS) published consensus criteria for
use in both research and public health settings and in particular in low- and middle-income
countries [11]. Thirdly, despite associations with stigma and poor mental health [8, 12, 13],
there are limited high-quality data on the impact of scabies and impetigo on health-related
quality of life (HRQoL). Improving our understanding of the morbidity associated with scabies
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is essential in assessing the potential benefit of interventions. Finally, the relationship between
scabies and secondary bacterial infection seems to be variable [10], with the latter appearing to
be less common in sub-Saharan Africa than in the Pacific, where the majority of studies to
date have been conducted [8].
Recently, mass drug administration (MDA) utilising oral ivermectin and 5% permethrin
cream has shown promise as an effective control strategy for scabies in areas of high endemic-
ity [14, 15]. A greater understanding of the disease burden due to scabies globally is required
in order to develop and scale-up control strategies [11]. A recent WHO Informal Consultation
on a Framework for Scabies Control identified the need to obtain high-quality population data
from regions outside the Pacific, and in particular in peri-urban settings, and to establish map-
ping methodologies as priorities to assist countries and WHO in developing international
guidelines for scabies control. A large outbreak of scabies occurred in Liberia in 2018, includ-
ing parts of the capital, Monrovia [16]. The Ministry of Health launched measures to control
transmission, including treatment of cases and their household contacts although detailed
impact evaluations were not conducted. There have been no population-based surveys under-
taken to see if scabies is a problem in other urban and peri-urban settings in the country where
no previous outbreak was reported. We therefore conducted a population-based prevalence
survey for scabies, secondary bacterial infection and impetigo in Monrovia, Liberia.
Materials and methods
Ethics statement
Written informed consent was obtained from participants aged 18 years and older and from
the parents or responsible adults for children. Verbal assent was obtained from children who
were able to provide it. The study was approved by the Ethics Committees of The London
School of Hygiene and Tropical Medicine, UK (Ref 17796) and the University of Liberia–
Pacific Institute for Research and Evaluation Institutional Review Board, Liberia (Ref 20-01-
195).
Study setting
The study was conducted in New Kru Town, a peri-urban coastal community in Bushrod
Island, Monrovia, Liberia. The area has a population of over 20,000 inhabitants [17] and is
composed of 25 distinct communities. New Kru Town was not targeted for scabies interven-
tion during the 2018 scabies outbreak and the underlying burden of infestation in this commu-
nity is not known.
Sample size calculation
We assumed an average household size of 4 and an average of 20 households enrolled per com-
munity cluster. Based on our predicted average cluster size of 80 and an intraclass correlation
coefficient (derived from previous surveys) we assumed a design-effect of 1.8. With a 20%
non-participation rate, we needed to enrol 1,200 individuals to have 80% power to detect a
prevalence of scabies of 15% with 3% precision. We therefore needed to enrol at least 15 com-
munity clusters of 20 households to achieve our sample size.
Study procedures
We conducted a cross-sectional population-based cluster-randomised household prevalence
survey over a 4-week period in February and March 2020. The survey team consisted of three
Liberian mid-level health workers (MLHWs) who had been trained to perform skin
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examinations and diagnose scabies and impetigo and a local guide to accompany them in each
community. We have reported on the training methodology and accuracy of the MLHWs
compared to a reference standard examination [18].
We randomly selected 15 of the 25 communities in New Kru Town as primary sampling
units (Fig 1). An initial community entry meeting was held with the 15 community chairper-
sons and information about the study was disseminated within each community prior to the
survey to enhance local acceptance. In each community a random sample of households was
surveyed to achieve a target sample size of 80 participants per community. Households were
selected using a random walk method. The centre point of the community was located by a
local guide and a random trajectory was determined using a computer-generated random
number between 0 and 359. A start point was determined by counting the number of buildings
along this trajectory to the community’s edge and using computer-generated random number
selection to determine a building number as the start point. From there a random trajectory
was chosen and all buildings within 5m to the left were included. When the edge of the com-
munity was reached, a further random trajectory was determined to continue the survey until
the required sample size was reached. Each building along the trajectory was recorded and
every household within an inhabited building was surveyed. If a household was absent, a revisit
was arranged for the same day if information on their return could be obtained; when this was
not possible, the house was logged as empty and excluded. For the purpose of the survey, a
household was defined as a group of people living together who eat from the same pot; all resi-
dents in selected households were invited for inclusion.
For each included household we collected data including observed household materials and
reported facilities, household size, and demographic details of the household head, including
age, gender, level of education and occupation. For each individual, we obtained equivalent
demographic details alongside a clinical history and conducted a standardised clinical exami-
nation for the detection of scabies, secondary bacterial infection and impetigo. If household
members were absent, we arranged a revisit for the same day where practicable; where this was
not possible, we logged them as absent. Data were collected electronically on Android devices
(Samsung Galaxy Tab A) using OpenDataKit (ODK, Seattle, USA, 2010).
We utilised a simplified version of the IACS consensus criteria for the diagnosis of “clinical”
or “suspected” scabies. Scabies was diagnosed if examiners identified burrows (category B1) or
found an individual with typical scabies lesions in a typical distribution and one (category C1)
or two (category B3) history features [11]. On the basis of our findings from a validation study,
conducted in Monrovia, of the IACS criteria and those of a previous study we limited exami-
nation to the face, upper limb and axilla and exposed areas of the lower limb for individuals
aged five and over, as this has been shown to have a sensitivity of more than 90% compared to
a full-body examination for detecting the presence of scabies lesions [18, 19], however if an
individual reported a lesion elsewhere that they wished to have examined, this was also
assessed. A wider distribution of lesions is typically found in infants and therefore children
aged less than five years old had a full skin examination performed [11]. Impetigo was diag-
nosed if discrete pustular lesions or ulcerated lesions associated with erythema, crusting, bullae
or frank pus. Impetigo diagnosed in individuals with scabies was considered to represent sec-
ondary bacterial infection. All sensitive examinations were performed in private and in the
presence of a responsible adult for examination of children. We classified the extent and sever-
ity of scabies and impetigo based on the number of lesions as previously described [19, 20].
We assessed HRQoL using a skin disease specific tool in individuals diagnosed with scabies,
secondary bacterial infection or impetigo. For individuals aged 16 years and older we utilised
the dermatology life quality index (DLQI)[21], for individuals aged seven to 15 years the Chil-
dren’s DLQI (CDLQI)[22], and for participants under seven a family DLQI (FDLQI)[23] was
PLOS NEGLECTED TROPICAL DISEASES Scabies prevalence in Monrovia
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008943 December 7, 2020 4 / 13
PLOS NEGLECTED TROPICAL DISEASES Scabies prevalence in Monrovia
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008943 December 7, 2020 5 / 13
completed by a parent or responsible adult. We only conducted one FDLQI for each affected
household with a child less than seven years old. Individuals who were diagnosed with scabies
were offered treatment with oral ivermectin or benzyl-benzoate lotion.
Statistical analysis
Data were analysed in STATA 16 (StataCorp, Texas, USA, 2019) and R 4.0 (The R Foundation
for Statistical Computing). For the purpose of analysis occupation was classified as unem-
ployed, student, market trader, business (other) and other; highest level of education com-
pleted was classified as no formal education, primary school education, secondary school
incomplete or complete and college/university complete; latrine type (taken as a potential
marker of socio-economic status) was classified as no latrine (open defecation), open pit
latrine or pour-flush toilet. Prevalence estimates for scabies, secondary bacterial infection and
impetigo were calculated accounting for clustering at the community and household level.
Adjusted odds ratios (aOR) were calculated for key demographic variables using a multivari-
able random-effects logistic regression model adjusted for age and gender and accounting for
clustering as above. The relationship between scabies and impetigo and HRQoL was assessed
by calculating the DLQI, the CDLQI for children aged 7 years and older and the FDLQI for
younger children.
Results
1,318 participants from 477 households, across 15 communities were enrolled (Fig 2). The
median age of participants was 21 years (IQR 9–34) and 61% were female. The mean number
of people surveyed in each community was 88 (range 78–106) (Table 1).
The prevalence of scabies across the 15 communities was 9.3% (N = 123, 95% CI: 6.5–
13.2%), with a range by community of 0.9–21.4% and the overall prevalence of impetigo or
infected scabies was 0.8% (N = 11, 95% CI: 0.4–1.9%). Cases of scabies were found in 87 of 477
households (18.2%). Of 11 patients diagnosed with impetigo, nine also had a diagnosis of sca-
bies. A large majority of scabies cases (76.4%) were classified as clinical scabies (IACS category
B3). Based on the number of lesions, over half of scabies cases were classified as severe (52%)
(Table 2). Overall, the prevalence of scabies was lower in females compared to males (6.9% vs
13.2%, aOR 0.50, 95% CI 0.29–0.73). This difference was due to higher prevalence in male chil-
dren than female children. The prevalence was also higher in the youngest age group com-
pared to the oldest, with 16.6% of those under five diagnosed with scabies compared to 7.2% of
those aged 35 and older (aOR 2.62, 95% CI 1.31–5.21). We did not find that any other collected
demographic or socio-economic variables were associated with scabies (Table 1) but there was
evidence of clustering at the community level (ICC 0.1 95% CI 0.04–0.26, p<0.001). No cases
of crusted scabies were detected.
Across the overall study population, 484 (36.7%) people reported having itch. The sensitiv-
ity of self-reported itch for an eventual diagnosis of scabies was 97.6% with a specificity of
69.5%. A similar picture was seen at household level, with a sensitivity of any individual in a
house reporting itch for a case of scabies in the house of 98.5% and a specificity of 56.2%. At
the cluster level there was a moderate correlation between the prevalence of itch and the preva-
lence of scabies (r = 0.6) (Table 3).
Fig 1. New Kru Town. Underlying map data is derived from OpenStreetMap. The cluster extents are derived from sampling points within
the survey.
https://doi.org/10.1371/journal.pntd.0008943.g001
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A HRQoL measure was completed with all participants (or their responsible adult when
appropriate) diagnosed with scabies and/or impetigo. The median score among adults com-
pleting the DLQI was 8 (IQR 4–11), reflecting a moderate effect on HRQoL, with 29% of adults
achieving scores which indicated a very or extremely large effect on quality of life. Among chil-
dren aged 7 years and older completing the CDLQI, the median score was 6 (IQR 4–10),
reflecting a small effect on quality of life, with 18% achieving scores which indicated a very or
extremely large effect. The median score of the FDLQI was 7 out of a possible score of 30 (IQR
6–9) consistent with a moderate impact on quality of life. Higher DLQI/CDQLI scores were
driven predominantly by higher scores on questions related to itch and feelings of embarrass-
ment or low mood related to their skin. There was evidence that the severity of disease, as mea-
sured by lesion counts, was associated with worse quality of life outcomes (Table 4).
Discussion
This community-based study conducted in peri-urban Monrovia is one of the first scabies
prevalence surveys to have been conducted across all age groups in recent years in sub-Saharan
Africa and is the first to utilise the 2020 IACS criteria for the diagnosis of scabies. We found an
overall prevalence of 9.3% but with a prevalence above 10% amongst children and that this was
associated with reduced HRQoL, predominantly driven by pruritus and impacts on mental
health.
The majority of scabies burden data available for sub Saharan Africa have been collected in
rural settings. The overall prevalence found in our survey is higher than the 6% found in a
Fig 2. Study enrolment flowchart.
https://doi.org/10.1371/journal.pntd.0008943.g002
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Table 1. Scabies prevalence by key demographic and household characteristics.
Characteristic N No. (%) with scabies Unadjusted� OR for scabies (95%
CI)




Male 514 68 (13.2) 1.0 <0.001 1.0 0.001
Female 804 55 (6.9) 0.38 (0.24–0.60), 0.50 (0.29–0.73)
Age
<5 205 34 (16.6) 3.13 (1.58–6.19) <0.001 2.62 (1.31–5.21) 0.008
5–9 138 16 (11.6) 2.21 (0.98–4.94) 1.80 (0.80–4.07)
10–14 142 18 (12.7) 1.88 (0.87–4.04) 1.66 (0.77–3.59)
15–24 258 15 (5.8) 0.80 (0.37–1.75) 0.76 (0.35–1.67)
25–34 254 17 (6.7) 0.84 (0.40–1.79) 0.88 (0.41–1.89)
35+ 321 23 (7.2) 1.0 1.0
Currently in education
No 895 85 (9.5) 1.0 0.956
Yes 423 38 (9.0) 1.01 (0.63–1.63)
Highest level of education completed (if not in education)
���
No formal education 313 41 (13.1) 1.0 0.11
K1-Grade 6 (Primary) 132 12 (9.1) 0.53 (0.24–1.56)
Grade 7–11 (Secondary incomplete) 204 15 (7.4) 0.49 (0.24–1.00)
Grade 12 (Secondary complete) 226 15 (6.6) 0.43 (0.21–0.88)
College/university 20 2 (10) 0.64 (0.11–3.68)
Occupation
Unemployed 399 47 (38.2) 1.0 0.36
Student 439 39 (31.7) 0.72 (0.42–1.24), P = 0.241
Market trader 183 12 (9.8) 0.51 (0.24–1.10), P = 0.085
Business (other) 130 13 (10.6) 0.59 (0.27–1.30), P = 0.190
Other 167 12 (9.8) 0.62 (0.29–1.36), P = 0.234
Household size
1–4 488 45 (9.2) 1.0 0.9
5–9 612 57 (9.3) 1.04 (0.59–1.82), P = 0.900
10+ 212 21 (9.9) 1.21 (0.51–2.89), P = 0.665
HOH education level completed
No formal education 220 24 (10.9) 1.0 0.20
K1-Grade 6 (Primary) 125 13 (10.4) 0.72 (0.25–2.12), P = 0.556
Grade 7–11 (Secondary incomplete) 260 32 (12.3) 1.07 (0.48–2.41), P = 0.862
Grade 12 (Secondary complete) 604 47 (7.8) 0.52 (0.24–1.12), P = 0.094
College/university 73 4 (5.5) 0.30 (0.07–1.31), P = 0.109
HOH employment status
Unemployed 226 25 (11.1) 1.0 0.55
Employed 1086 98 (9.0) 0.81 (0.41–1.61)
Latrine type
No latrine (open defecation) 159 16 (10.1) 1.0 0.57
Open pit latrine 80 5 (6.3) 0.49 (0.13–1.90)
Pour-flush toilet 1071 102 (9.5) 0.75 (0.34–1.67)
Latrine privacy
Private 549 49 (8.93) 1.0 0.983
Shared 763 74 (9.70) 1.01 (0.58–1.75)
�Adjusted for clustering at the community and household level
��Adjusted for age, gender and clustering at the community and household level
��� Not included in multivariable logistic regression model due to suspected collinearity with age.
https://doi.org/10.1371/journal.pntd.0008943.t001
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rural survey in Tanzania [24] and the 2.8% found in a rural survey in Cameroon [25]; this may
in part reflect the increased risk of infection that is thought to arise from overcrowded condi-
tions and which may be more representative of our peri-urban study population [26]. The
prevalence of scabies in our survey was found to be higher in younger age groups, which is
consistent with other studies [10, 24]. The highest burden was found in children under 5 years
of age (16.6%), which is at the higher end of prevalence figures seen among this age group in
other West African studies [27–31]. However, whilst the highest prevalence was seen among
children, the results of our survey indicate that scabies carries a substantial burden across all
age groups. We found very strong evidence that the risk of scabies was twice as high in male
children compared to females, which has also been reported in some other studies [20], but
did not find any evidence of statistical associations between other demographic or socioeco-
nomic characteristics and scabies. This likely reflects a true absence of association although it
is possible that our study population was too homogeneous to detect an association with these
variables.
We did not find a high burden of secondary bacterial infection among the study population,
suggesting that this may not be a substantial risk arising from scabies in this setting. We con-
ducted out study in the dry season, and in other West African settings impetigo has been
shown to increase markedly in the wet season and we may therefore have underestimated the
true burden of impetigo in this setting [27, 28]. Alternatively there may be other factors such
as differential rates of S.aureus and S.pyogenes carriage or differences in the skin microbiome
which impact impetigo rates. Further study in this area is a priority. Regardless, the impact of
scabies itself appears to be significant. Over half of all scabies cases diagnosed during the sur-
vey (52%) were categorised as extensive, with individuals each having 50 or more lesions. As
previously reported, the sensitivity of MLHWs in diagnosing scabies is greater in more exten-
sive disease [18, 32] and it is possible that some cases of less extensive disease were not cap-
tured, however the number of cases of extensive disease indicates a substantial unmet need in
scabies management. Our study further indicates that scabies has a large effect on quality of
life. From our validation study, extent of disease, as measured by lesion counts, correlated with
the degree of itchiness experienced by the patient [18]. Pruritic skin diseases are known to
have a negative impact on quality of life and our data suggests that pruritus associated with sca-
bies is one of the major drivers of the impact of infestation on HRQoL scores. The median
CDLQI score of 6 for children with scabies is similar to that reported in a previous study in
Ethiopia [12]. Though the numbers were too small for formal analysis, those scoring in the
highest three categories on the DLQI and CDLQI were most commonly those with extensive
Table 2. Prevalence of scabies and impetigo and scabies diagnostic characteristics.
Prevalence of disease in study population N (%, 95%CI)
Scabies 123 (9.3, 6.5–13.2)
Secondary Bacterial Infections 11 (0.7, 0.3–1.3)
Impetigo 2 (0.2, 0.03–0.6)
Scabies severity
Mild scabies (1–10 lesions) 21 (17.1)
Moderate scabies (11–49 lesions) 38 (30.9)
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disease as measured by lesion counts. It is possible therefore that measures to reduce the bur-
den of scabies would bring substantial benefit to individuals.
The burden of scabies found in this peri-urban community is substantial and highlights
that further consideration should be given to population-level management. The 2019 WHO
Informal Consultation for a scabies control programme posited that communities with preva-
lence rates�10% should be considered for MDA programmes [33], however there is currently
no formal guidance and further research is needed to inform the development of scabies con-
trol strategies. Whilst itchiness was highly sensitive for the diagnosis of scabies it had extremely
poor specificity at both the individual and the household level suggesting that it is unlikely to
be useful marker for guiding decision making. Further work is needed to assess whether MDA
would have a sustained impact in reducing the prevalence of scabies in sub-Saharan African
settings, as has been the case in studies in Fiji [14, 34] and to understand what would be the
most appropriate treatment to use.
Limitations
Our study has some limitations. Firstly, not all individuals were present at the time of examina-
tion and this may have affected our overall prevalence estimate, and associations we found
with risk of scabies, especially if presence or absence was associated with scabies. The demo-
graphic distribution of our study population is in line with Liberian data for urban regions
Table 3. Association between scabies diagnosis and self-reported history of itch.
Participant-reported itch
history (N = 1318)
N (%) survey
population




















history (N = 477)
N (%)
households














Table 4. DLQI scores of scabies cases and stratification by scabies severity.
DLQI score (N = 58) N (%) of cases N (%) mild scabies N (%) moderate scabies N (%) severe scabies
0–1 (no effect on patient’s life) 4 (6.9) 3 (75) 0 (0) 1 (25)
2–5 (small effect) 16 (27.6) 5 (31) 7 (44) 4 (25)
6–10 (moderate effect) 21 (36.2) 4 (19) 7 (33) 10 (48)
11–20 (very large effect) 15 (25.9) 1 (7) 4 (27) 10 (67)
21–30 (extremely large effect) 2 (3.5) 0 (0) 0 (0) 2 (100)
CDLQI score (N = 28)
0–1 (no effect on child’s life) 2 (7.1) 0 (0) 2 (100) 0 (0)
2–6 (small effect) 13 (46.4) 3 (23) 7 (54) 3 (23)
7–12 (moderate effect) 8 (28.6) 1 (13) 1 (13) 6 (75)
13–18 (very large effect) 4 (14.3) 0 (0) 1 (25) 3 (75)
19–30 (extremely large effect) 1 (3.6) 0 (0) 0 (0) 1 (100)
FDLQI score (N = 38), median (IQR) 7/30 (6–9))
https://doi.org/10.1371/journal.pntd.0008943.t004
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which reduces the risk that our prevalence estimates may be biased by unrepresentative sam-
pling [35]. Secondly, the sensitivity of MLHWs is lower than an expert examiner which is likely
to have resulted in under-estimation of the true burden of disease and likely explains the low
rates of burrows identified. The MLHWs who undertook the examinations in this survey
underwent training and validation as part of our overall study in Liberia and were found to
have similar performance to staff who have undertaken surveys in many other studies, so we
do not believe this is a major limitation [18]. Thirdly, our study was conducted in a single com-
munity within Monrovia and may not be generalisable to other peri-urban settings. Finally,
the DLQI, CDLQI and FDLQI have not been validated for use in Liberia. The primary lan-
guage in Liberia is English. A consensus was achieved among the MLHW for minor adjust-
ments to the phrasing of questions that would make them appropriate for use in this setting
and it was agreed that the content of the questions was still applicable. Further work to for-
mally validate these tools in similar settings would provide increased confidence of findings in
future studies, enhancing understanding of the full burden of common skin conditions in
these settings.
Conclusions
Our study highlights that scabies carries a substantial burden across all age groups in this peri-
urban community in Monrovia, including a considerable impact on HRQoL for those with the
disease. The robust methodology used provides high quality community-level data which
makes an important contribution to our understanding of the burden of scabies and impetigo
in low resource settings. Further work is needed to increase our understanding of scabies epi-
demiology across different settings and regions in sub-Saharan Africa. Understanding the
impact of disease management strategies, including MDA, on scabies prevalence in these set-
tings is essential to inform the development of effective population-level scabies control
programmes.
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